RecruitingNCT03520699

Beijing Friendship Hospital Metabolic Surgery Database

Beijing Friendship Hospital Metabolic Surgery Clinical Database


Sponsor

Beijing Friendship Hospital

Enrollment

3,000 participants

Start Date

Dec 1, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

Metabolic surgery, as a recognition treatment option for patients with clinical morbid obesity, is gaining increasing appreciation. In addition to substantial weight loss, emerging studies have highlighted that metabolic surgery can substantially ameliorate obesity-related metabolic diseases, including but not limited to type 2 diabetes mellitus (T2DM), hypertension, dyslipidemia, obstructive sleep apnea-hypopnea syndrome (OSAHS) and polycystic ovary syndrome (PCOS)in severely obese patients. However, further investigations with larger sample size and longer observation time still needed to clarity the efficacy and safety of metabolic surgery in Chinese patients with obesity and encouraging future research in this field.


Eligibility

Inclusion Criteria1

  • be able to receive metabolic surgery (LSG or LRYGB)

Exclusion Criteria1

  • can not be able to understand and willing to participate in this registry with signature

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Beijing Friendship Hospital

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03520699


Related Trials